1. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO‐HSCT) FOR PATIENTS WITH RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (R/R SALCL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY‐EBMT. (June 2017) Authors: Domingo Domenech, E.; Boumendil, A.; Climent, F.; Socié, G.; Kroschinsky, F.; Finel, H.; Vandenbergue, E.; Nemet, D.; Stelljes, M.; Bittenbring, J.; Montoto, S.; Sureda, A.; Dreger, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BRENTUXIMAB VEDOTIN FOR RELAPSED HODGKIN LYMPHOMA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: a RETROSPECTIVE STUDY OF THE EBMT LYMPHOMA WORKING PARTY. (June 2017) Authors: Bazarbachi, A.; Boumendil, A.; Finel, H.; Mohty, M.; Castagna, L.; Blaise, D.; Peggs, K.; Afanasyev, B.; Diez‐Martin, J.; Corradini, P.; Socié, G.; Robinson, S.; Gutiérrez‐García, G.; Bonifazi, F.; Yakoub‐Agha, I.; Gülbas, Z.; Bloor, A.; Delage, J.; Esquirol, A.; Malladi, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY. (12th June 2019) Authors: Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Kanfer, E.; Peggs, K.; Fuesrt, S.; Ram, R.; Marjit, E.; Vandenberghe, E.; Afanasyev, B.; Wulf, G.; Maertens, J.; Tsolukani, A.; Schapp, N.; Beelen, D.; Chalandon, Y.; Gurman, G.; Finke, J.; Bron, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REGIMEN FOR HAPLOIDENTICAL TRANSPLANTS WITH POST‐TRANSPLANT CYCLOPHOSPHAMIDE FOR LYMPHOMA: A REPORT OF THE EBMT LWP. (12th June 2019) Authors: Bazarbachi, A.; Boumendil, A.; Finel, H.; Castagna, L.; Dominietto, A.; Blaise, D.; Diez‐Martin, J.; Tischer, J.; Gülbas, Z.; Labussière Wallet, H.; Lopez Corral, L.; Mohty, M.; Koc, Y.; Yakoub‐Agha, I.; Schmid, C.; el Cheikh, J.; Arat, M.; Forcade, E.; Dreger, P.; Rocha, V. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high‐risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party‐EBMT. (8th November 2021) Authors: Gutiérrez‐García, G.; Martínez, C.; Boumendil, A.; Finel, H.; Malladi, R.; Afanasyev, B.; Tsoulkani, A.; Wilson, K. M. O.; Bloor, A.; Nikoloudis, M.; Richardson, D.; López‐Corral, L.; Castagna, L.; Cornelissen, J.; Giltat, A.; Collin, M.; Fanin, R.; Bonifazi, F.; Robinson, S.; Montoto, S. Journal: British journal of haematology Issue: Volume 196:Number 4(2022) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†. (8th March 2016) Authors: Robinson, S. P.; Boumendil, A.; Finel, H.; Schouten, H.; Ehninger, G.; Maertens, J.; Crawley, C.; Rambaldi, A.; Russell, N.; Anders, W.; Blaise, D.; Yakoub-Agha, I.; Ganser, A.; Castagna, L.; Volin, L.; Cahn, J.-Y.; Montoto, S.; Dreger, P. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE CELL LYMPHOMA AFTER FIRST LINE INTENSIVE CHEMO‐IMMUNOTHERAPY AND ASCT – A RETROSPECTIVE STUDY FROM THE LWP‐EBMT. (12th June 2019) Authors: Burney, C.N.; Robinson, S.; Boumendil, A.; Finel, H.; Khvedelidze, I.; Hunter, H.; Poire, X.; Lioure, B.; Peggs, K.; Foa, R.; Pillai, S.; van Meerten, T.; Bargay Lleonart, J.; Schmid, C.; Vergote, V.; Ganser, A.; Castagna, L.; Mufti, G.; Montoto, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗